Fresenius

AlphaSense Accelerates Global Growth Strategy with New Office in Frankfurt

Retrieved on: 
Tuesday, September 20, 2022

FRANKFURT, Germany, Sept. 20, 2022 /PRNewswire/ -- AlphaSense, the leading market intelligence and search platform, today announced the opening of its first office in Germany. The expansion will support AlphaSense's growing footprint in Western Europe in response to strong customer demand from the region. The new office space, located in Frankfurt's Innenstadt—one of Europe's leading commercial, cultural, and business centers and just steps from Goetheplatz—doubles AlphaSense's physical footprint in Europe and will bolster the company's focus on growing and supporting its customer base locally.

Key Points: 
  • FRANKFURT, Germany, Sept. 20, 2022 /PRNewswire/ -- AlphaSense , the leading market intelligence and search platform, today announced the opening of its first office in Germany.
  • While the search for a permanent country manager is underway, the office will be managed in the meantime by Peter Kovacs, Senior Vice President within AlphaSense's Global Sales team.
  • "With our longstanding presence in London and Helsinki, expanding to Frankfurt as a core economic hub on the continent is the natural next step in our European growth strategy."
  • Headquartered in New York City, AlphaSense employs over 1,000 people across offices in the U.S., U.K., Finland, Germany, and India.

AlphaSense Accelerates Global Growth Strategy with New Office in Frankfurt

Retrieved on: 
Tuesday, September 20, 2022

FRANKFURT, Germany, Sept. 20, 2022 /PRNewswire/ -- AlphaSense, the leading market intelligence and search platform, today announced the opening of its first office in Germany. The expansion will support AlphaSense's growing footprint in Western Europe in response to strong customer demand from the region. The new office space, located in Frankfurt's Innenstadt—one of Europe's leading commercial, cultural, and business centers and just steps from Goetheplatz—doubles AlphaSense's physical footprint in Europe and will bolster the company's focus on growing and supporting its customer base locally.

Key Points: 
  • FRANKFURT, Germany, Sept. 20, 2022 /PRNewswire/ -- AlphaSense , the leading market intelligence and search platform, today announced the opening of its first office in Germany.
  • While the search for a permanent country manager is underway, the office will be managed in the meantime by Peter Kovacs, Senior Vice President within AlphaSense's Global Sales team.
  • "With our longstanding presence in London and Helsinki, expanding to Frankfurt as a core economic hub on the continent is the natural next step in our European growth strategy."
  • Headquartered in New York City, AlphaSense employs over 1,000 people across offices in the U.S., U.K., Finland, Germany, and India.

USOSM Recruits Robert Manning as Vice President of Business Development

Retrieved on: 
Tuesday, September 13, 2022

IRVING, Texas, Sept. 13, 2022 /PRNewswire-PRWeb/ -- U.S. Oral Surgery Management (USOSM) – a specialty management services company that exclusively serves premier oral and maxillofacial surgeons – has named healthcare industry veteran Robert Manning as a vice president of business development. In his new position, Manning will be responsible for the strategic growth and development of USOSM by seeking out new surgeon partners and ensuring a smooth transition during the partnership process.

Key Points: 
  • Oral Surgery Management (USOSM) has named healthcare industry veteran Robert Manning as a vice president of business development.
  • Oral Surgery Management ( USOSM) a specialty management services company that exclusively serves premier oral and maxillofacial surgeons has named healthcare industry veteran Robert Manning as a vice president of business development.
  • "We're excited to announce Robert Manning has joined USOSM as a vice president of business development," said Richard Hall, USOSM president and CEO.
  • Before that, Manning served as vice president of business development at Mednax Inc.

CytoSorbents Reports Second Quarter 2022 Financial and Operational Results

Retrieved on: 
Tuesday, August 2, 2022

Comparison for the three months ended June 30, 2022 and 2021:

Key Points: 
  • Comparison for the three months ended June 30, 2022 and 2021:
    Total revenue, including product revenue and grant income, for the second quarter of 2022 was $8.5 million, down 39% from $12.0 million in the second quarter of 2021.
  • We estimate that demand for CytoSorb to treat COVID-19 patients was de minimis in the second quarter of 2022 as compared to approximately $1.7 million in the second quarter of 2021.
  • For additional information, please see the Company's Form 10-Q for the period ended June 30, 2022 filed on August 2, 2022 on http://www.sec.gov .
  • The Company will conduct its second quarter 2022 results call today at 4:30 p.m. Eastern time.

Clinical Infant Nutrition Global Markets Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 22, 2022

The "Clinical Infant Nutrition: Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Clinical Infant Nutrition: Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • The current report will provide detailed information regarding the infant nutrition market.
  • It analyzes the market trends of infant nutrition with data from 2020, estimates from 2021, projections of compound annual growth rates (CAGR) through 2026 (i.e., forecast period 2021 through 2026) and regional markets of infant nutrition devices.
  • This report will highlight the current and future market potential for infant nutrition, as well as a detailed analysis of the competitive environment.

Greater Boston Convention and Visitors Bureau Chooses Allen & Gerritsen as Brand Agency of Record

Retrieved on: 
Thursday, July 7, 2022

A&G will also lead the GBCVB through an organizational rebrand that will reposition the organization within the travel industry.

Key Points: 
  • A&G will also lead the GBCVB through an organizational rebrand that will reposition the organization within the travel industry.
  • "The time has come for Boston to tell its full story, to own that story and to no longer allow others to tell it for us.
  • "This is about the future and how we upend preconceived notions of Boston as we invite visitors to join us in crafting new narratives.
  • The Greater Boston Convention & Visitors Bureau (GBCVB) is the primary private sector marketing and visitor services organization charged with the development of meetings, conventions and tourism-related business.

Alio Announces Patient and Family Advisory Council

Retrieved on: 
Tuesday, May 17, 2022

BROOMFIELD, Colo., May 17, 2022 /PRNewswire/ -- Today, Alio announced a significant milestone with the formation of its Patient and Family Advisory Council (PFAC), making it one of the first councils of its kind in the remote patient monitoring space. The council includes patients across the US who are facing chronic kidney disease (CKD), dialysis treatment, and kidney transplantation.

Key Points: 
  • Continuing focus on dialysis patients, Alio seeks to expand patient advocacy and gain broader patient perspective
    BROOMFIELD, Colo., May 17, 2022 /PRNewswire/ --Today, Alio announced a significant milestone with the formation of its Patient and Family Advisory Council (PFAC), making it one of the first councils of its kind in the remote patient monitoring space.
  • The Alio Patient and Family Advisory Council is chaired by Ms. Terry Foust Litchfield, a renowned dialysis patient advocate and industry pioneer.
  • The Alio council includes members with experience in advocacy and patient education.
  • Alio, Inc. (Broomfield, CO), is a medical technology company bringing peace of mind to people with chronic conditions through noninvasive, wireless remote patient monitoring.

Global Dialysate Market to 2027 - Featuring Baxter, Fresenius and Rockwell Medical Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, April 29, 2022

The global dialysate market is anticipated to grow at a considerable CAGR during the forecast period.

Key Points: 
  • The global dialysate market is anticipated to grow at a considerable CAGR during the forecast period.
  • The growing incidence of kidney disorders in geriatric population is a key factor driving the growth of the global dialysate market.
  • Some of the companies operating in the global dialysate market include Weigao, Farmasol, B.Brauna, Baxter, Fresenius among others.
  • Insights about market determinants that are stimulating the global dialysate market.

Eagle Pharmaceuticals Reaches Settlement Agreement with Hospira Related to BENDEKA® (bendamustine hydrochloride) until January 17, 2028

Retrieved on: 
Tuesday, April 19, 2022

WOODCLIFF LAKE, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (Eagle or the Company) today announced that it has reached a settlement agreement with Hospira, Inc (Hospira).

Key Points: 
  • WOODCLIFF LAKE, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (Eagle or the Company) today announced that it has reached a settlement agreement with Hospira, Inc (Hospira).
  • Eagle had asserted two Orange Book-listed patents against Hospira related to its new drug application (NDA) referencing BENDEKA.
  • The settlement agreement provides that Hospira has the right to market its product beginning January 17, 2028, or earlier based on certain circumstances.
  • The settlement agreement is confidential and subject to review by the U.S. Federal Trade Commission and the U.S. Department of Justice.

New Research Affirms Increase in Access, Equity of COVID-19 Vaccines Administered in Dialysis Centers

Retrieved on: 
Monday, April 4, 2022

DENVER and WALTHAM, Mass., April 4, 2022 /PRNewswire/ -- A federal partnership established to help increase access to COVID-19 vaccines for end stage kidney disease (ESKD) patients receiving dialysis was successful in reducing racial disparities in vaccination coverage, new research published today in JAMA Internal Medicine affirms. Compared to white patients, Hispanic, Black and Asian patients were more likely to receive at least one dose of COVID-19 vaccine in a dialysis center.

Key Points: 
  • Both providers received allocations of COVID-19 vaccines from the federal government to administer to patients in dialysis centers and distribute to other dialysis providers across the country.
  • "We were steadfast in our advocacy efforts to support patients with kidney failure by providing access to the vaccine through the pandemic.
  • The researchers recommend that public health agencies and policymakers prioritize dialysis centers for federal vaccine allocations and on-site vaccine administration in the future.
  • As ofDecember 31, 2021, DaVita served 203,000 patients at 2,815 outpatient dialysis centers in the U.S.